HI Hemostemix Inc. Stock: price and directors' dealings · Canada · SEDISource id SEDI:hemostemix-inc CA · SEDI Mcap CA$14.8M Track the Hemostemix Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Market capitalisation: €14.8m. The latest transaction was filed on 10 August 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: Swanberg, Loran Lavern. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
▲ 4 - Director of Issuer · Executives · 20 May 2026
1,265,000 shares @ CA$0.055 0.49% mcap 12.8% of flow Common Shares SEDI:4762453 Canonical exit: 18 Aug 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 20 May 2026
1,265,000 shares @ CA$0.055 0.49% mcap 12.8% of flow Common Shares SEDI:4762432 Canonical exit: 18 Aug 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 9 Feb 2026
1,265,000 shares @ CA$0.09 20.7% of flow Common Shares SEDI:4762425 Canonical exit: 10 May 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 9 Feb 2026
1,265,000 shares @ CA$0.09 20.7% of flow Common Shares SEDI:4762422 Canonical exit: 10 May 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 26 Jun 2026
1,000,000 shares Warrants SEDI:4762386 Canonical exit: 24 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 26 Jun 2026
2,000,000 shares @ CA$0.05 0.69% mcap 18.1% of flow Common Shares SEDI:4762377 Canonical exit: 24 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 10 Jun 2026
22,055 shares @ CA$0.06 0.0092% mcap 0.2% of flow Common Shares SEDI:4762338 Canonical exit: 8 Sept 2026 (T+90) ● 4 - Director of Issuer · Executives · 27 Jun 2025
625,000 shares Warrants SEDI:4762244 ▲ 4 - Director of Issuer · Executives · 10 Jun 2026
26,500 shares @ CA$0.0575 0.011% mcap 0.3% of flow Common Shares SEDI:4762228 Canonical exit: 8 Sept 2026 (T+90) ● 4 - Director of Issuer · Executives · 23 Jul 2025
400,000 shares @ CA$0.10 7.3% of flow Common Shares SEDI:4762223 ● 4 - Director of Issuer · Executives · 23 Jul 2025
400,000 shares Warrants SEDI:4762174 ● 4 - Director of Issuer · Executives · 23 Jul 2025
400,000 shares @ CA$0.10 62.3% of flow Common Shares SEDI:4762149 ◇ 4 - Director of Issuer · Executives · 24 Jul 2025
290,000 shares Options SEDI:4762043 ◇ 4 - Director of Issuer · Executives · 31 Dec 2025
416,500 shares Options SEDI:4762037 ▲ 4 - Director of Issuer · Executives · 10 Jun 2026
20,000 shares @ CA$0.06 0.0084% mcap 1.9% of flow Common Shares SEDI:4762030 Canonical exit: 8 Sept 2026 (T+90) ◇ 4 - Director of Issuer · Executives · 30 Jul 2026
525,000 shares @ CA$0.06 0.19% mcap 12.5% of flow Options SEDI:4758019 ◇ 4 - Director of Issuer · Executives · 22 Jul 2026
385,000 shares @ CA$0.06 0.14% mcap 100.0% of flow Options SEDI:4757119 ◇ 4 - Director of Issuer · Executives · 22 Jul 2026
1,730,000 shares Options SEDI:4756118 ▲ 4 - Director of Issuer · Executives · 25 Jun 2026
1,000,000 shares @ CA$0.12 54.5% of flow Warrants SEDI:4741236 Canonical exit: 23 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 25 Jun 2026
2,000,000 shares @ CA$0.05 45.5% of flow Common Shares SEDI:4741235 Canonical exit: 23 Sept 2026 (T+90) ● 4 - Director of Issuer · Executives · 3 Nov 2025
1,500,000 shares Warrants SEDI:4599622 ● 4 - Director of Issuer · Executives · 23 Jul 2025
100,000 shares @ CA$0.15 2.7% of flow Warrants SEDI:4550455 关于 Hemostemix Inc. Hemostemix Inc. 是一家在多伦多证券交易所上市的公司，专注于开发心血管疾病的再生疗法。该公司利用干细胞技术来改善患者健康。